Home Halogens 2-(dimethylamino)ethyl 2-(4-chlorophenoxy)acetate hydrochloride

2-(dimethylamino)ethyl 2-(4-chlorophenoxy)acetate hydrochloride

CAS No.:
3685-84-5
Catalog Number:
AG0034L0
Molecular Formula:
C12H17Cl2NO3
Molecular Weight:
294.1743
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$13
- +
5g
95%
In Stock USA
United States
$19
- +
25g
95%
In Stock USA
United States
$63
- +
100g
98%
In Stock USA
United States
$188
- +
Product Description
Catalog Number:
AG0034L0
Chemical Name:
2-(dimethylamino)ethyl 2-(4-chlorophenoxy)acetate hydrochloride
CAS Number:
3685-84-5
Molecular Formula:
C12H17Cl2NO3
Molecular Weight:
294.1743
MDL Number:
MFCD00012533
IUPAC Name:
2-(dimethylamino)ethyl 2-(4-chlorophenoxy)acetate;hydrochloride
InChI:
InChI=1S/C12H16ClNO3.ClH/c1-14(2)7-8-16-12(15)9-17-11-5-3-10(13)4-6-11;/h3-6H,7-9H2,1-2H3;1H
InChI Key:
FIVHOHCAXWQPGC-UHFFFAOYSA-N
SMILES:
CN(CCOC(=O)COc1ccc(cc1)Cl)C.Cl
EC Number:
222-975-3
UNII:
5BK3070BDY
Properties
Complexity:
228  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
293.059g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
294.172g/mol
Monoisotopic Mass:
293.059g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
38.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Construction and performance characteristics of new ion selective electrodes based on carbon nanotubes for determination of meclofenoxate hydrochloride. Analytica chimica acta 20120612
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
A simple and sensitive HPLC method for quantification of the metabolin of meclofenoxate in human plasma. Journal of chromatographic science 20100101
Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. Neurochemistry international 20091101
Bioequivalence and pharmacokinetic comparison of a single 200-mg dose of meclofenoxate hydrochloride capsule and tablet formulations in healthy Chinese adult male volunteers: a randomized sequence, open-label, two-period crossover study. Clinical therapeutics 20080901
Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine. Brain research 20080327
[Effects of piracetam and meclofenoxate on the brain NMDA and nicotinic receptors in mice with different exploratory efficacy in the cross maze test]. Eksperimental'naia i klinicheskaia farmakologiia 20080101
[Effects of nicotinic cholinoreceptor ligands and nootropic drugs on the spontaneous exploratory activity in a labyrinth in mice]. Eksperimental'naia i klinicheskaia farmakologiia 20080101
Further evidence of centrophenoxine mediated protection in aluminium exposed rats by biochemical and light microscopy analysis. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20071201
Kinetic study on the degradation of meclophenoxate hydrochloride in alkaline aqueous solutions by high performance liquid chromatography. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20070101
Stability-indicating electrochemical methods for the determination of meclophenoxate hydrochloride and pyritinol dihydrochloride using ion-selective membrane electrodes. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20070101
Reversal of an aluminium induced alteration in redox status in different regions of rat brain by administration of centrophenoxine. Molecular and cellular biochemistry 20061001
Evidence for centrophenoxine as a protective drug in aluminium induced behavioral and biochemical alteration in rat brain. Molecular and cellular biochemistry 20061001
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Modulatory effects of centrophenoxine on different regions of ageing rat brain. Experimental gerontology 20051001
Centrophenoxine improves chronic cerebral ischemia induced cognitive deficit and neuronal degeneration in rats. Acta pharmacologica Sinica 20041201
Brain cholinesterases: III. Future perspectives of AD research and clinical practice. Medical hypotheses 20040101
Effect of centrophenoxine on water-immersion restraint stress- and chemically-induced gastric ulcers in rats. Research communications in molecular pathology and pharmacology 20030101
Pharmacological interventions against aging through the cell plasma membrane: a review of the experimental results obtained in animals and humans. Annals of the New York Academy of Sciences 20020401
Can nootropic drugs be effective against the impact of ethanol teratogenicity on cognitive performance? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010201
Memory effects of the new derivative of the p-chlorophenoxyacetic acid adafenoxate compared to the effects of some cognition-enhancing drugs in rats. Arzneimittel-Forschung 19890901
[Pharmacological analysis of memory disorders of different origins]. Biulleten' eksperimental'noi biologii i meditsiny 19890601
Effect of nicergoline on learning and memory. Methods and findings in experimental and clinical pharmacology 19880701
[Circadian rhythm studies on the prenatal toxic effect of cyclophosphamide and centrophenoxine in Wistar rats]. Anatomischer Anzeiger 19850101
Properties